| |
|
|
|
Millendo Therapeutics Inc  
|
|
1.78 -0.05 (-0.03%) |
10-23 16:00 |
|
Open: |
1.84 |
Pre close: |
1.83 |
Target:
|
2.24
|
|
High: |
1.84 |
Low: |
1.77 |
Resistance:
|
1.92
2.24
|
|
Volume: |
180,161 |
Market Cap: |
34M |
Support:
|
1.65
1.49
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.78
 |
MACD |
MACD(12,26):
|
0.04  |
|
MA(20): |
1.67 |
Signal(12,26,9): |
0.02 |
|
MA(100): |
1.82 |
Stochastic Oscillator |
%K(14,3):
|
74.94 |
|
MA(250): |
4.22 |
%D(3): |
68.75 |
|
Average Volume(K) |
3-Month: |
39761
|
52-Week |
High:
|
9.88 |
|
10-Days: |
33670 |
Low: |
1.26 |
|
RSI |
RSI(14):
|
56.93 |
Change(%): |
-76.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.869 |
Return on Equity (ttm) |
-94.0 |
Shares Out. (M) |
19.00 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-47.2 |
Shares Float (M) |
13.89 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
11.30 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
65.47 |
|
Forward EPS |
-3.250 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
545 |
|
Book Value (p.s.) |
2.330 |
EBITDA (p.s.) |
-2.483 |
P/E |
-0.62 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.76 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-38.08 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-19.09 |
P/CF |
-0.89 |
|
|
|
|
|
|
